BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hippocampus
,
Biofuel
,
Ciprofibrate
,
rs2476601
,
FOXP1
,
Fatty acid metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ttw
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Liver
Thyroid gland
Myometrium
Joint synovium
Transverse colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Idiopathic arterial calcification of infancy
Low blood pressure
Hypertrophy of bone
Arthropathy
Disorder of glucose metabolism
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Amifostine
ascaris suum 14-kDa antigen
Probiotic mixture
anacardic acid
CAL 101
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
VPS26A
SNRNP40
TNFRSF11A
IFRD2
NRF1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Structure-Aided Development of Small-Molecule Inhibitors of ENPP1, the Extracellular Phosphodiestera…
ENPP1 Immunobiology as a Therapeutic Target.
Discovery of VH domains that allosterically inhibit ENPP1.
ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway.
NPP1 and TNAP hydrolyze ATP synergistically during biomineralization.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Pati…
Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With Previously Treated Ch…
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukem…
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab,…
A Study of LY2157299 in Participants With Hepatocellular Carcinoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ